SEELY LYNN sold 0.5% of their position (438.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $10.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0001327111-26-000001
+174.56K
Net shares
Net buyer
$10.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
175K acquired · 438.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
32.2%
2/9/2026
62.16K→82.16K
Common Stock
Direct
Shares
−438.00
Price / share
$23.12
Trade value
$10.13K
% of position
0.5%
2/10/2026
82.16K→81.72K
Total
Net shares
+19.56K
Net value
-$10.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | A · Award | +20K | — | — | 32.2% | 62.16K | 82.16K |
| Common Stock Direct | 2/10/2026 | S · Sale | −438.00 | $23.12 | $10.13K | 0.5% | 82.16K | 81.72K |
| Total | +19.56K | -$10.13K | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Common Stock
155K shares
Shares
+155K
Strike price
23.71
Held after
155K
Exercisable
—
2/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Common Stock155K shares | 2/10/2026 | A · Award | +155K | 23.71 | — | 155K |